NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

CBS Early Show joins ranks of zero-star health stories

Posted By

Tags

Another terribly incomplete story on a morning segment on network TV.

It was about an osteoporosis drug now being looked at for poorly healing bone fractures.

CBS put a crawl under this story reading “Stem cells to build better bones.” And then failed to mention stem cells even one time in the story.

They also had:

* No discussion of costs – which are significant.

* No discussion of evidence, which is limited.

* No discussion of the source of the information, but we can assume it was a recent study for which there was no control group to compare the results to. Furthermore, that study has not yet been published and the full results have not been reviewed by other experts. These are important caveats that the story should have mentioned.

Instead of data, the segment gushed calling it “godsend…really exciting…very important…could be lifesaving.”

Complete story review on

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Eskimo

April 16, 2009 at 4:56 pm

Funny, the University of Rochester (more like, Eli Lilly) press release also mentions stem cells. It justifies this by saying that Forteo/teriparatide stimulates bone stem cells. Quite the marketing switcheroo!